Tag: Competition

Displaying 1321 - 1340 of 2233 results.

Pages

The Federal Trade Commission’s staff submitted a comment to the U.S. Federal Energy Regulatory Commission providing views on how energy regulators should apply the revised Horizontal Merger Guidelines.
The Federal Trade Commission today released the agenda for a public workshop addressing legal and policy issues surrounding the inclusion of patented technology in collaboratively set industry standards. The workshop will be held on June 21, 2011, starting at 9:30 a.m., at the FTC’s Conference...
Universal Health Services, Inc. (UHS) is seeking the approval of the Federal Trade Commission to sell its Las Vegas psychiatric facilities, including Montevista Hospital and Red Rock Behavioral Health Hospital, to Dr. Soon Kim through Signature Health Services, LLC, which does business as Aurora...
The FTC required Grifols, S.A., a manufacturer of plasma-derived drugs, to make significant divestitures as part of a settlement allowing Grifols to acquire a leading plasma-derived drug manufacturer, Talecris Biotherapeutics Holdings Corp. It resolves FTC charges that Grifols’...
The Federal Trade Commission will require Grifols, S.A., a manufacturer of plasma-derived drugs, to make significant divestitures as part of a settlement allowing Grifols to acquire a leading plasma-derived drug manufacturer, Talecris Biotherapeutics Holdings Corp.
The Commission required Irving Oil Terminals Inc. and Irving Oil Limited to relinquish the rights to terminal and pipeline assets in Maine that Irving acquired from ExxonMobil, to maintain competition in gasoline and distillates terminaling services in the South Portland and Bangor/...
The Federal Trade Commission will require Irving Oil Terminals Inc. and Irving Oil Limited (collectively, Irving) to relinquish the rights to terminal and pipeline assets in Maine that Irving acquired from ExxonMobil, to maintain competition in gasoline and distillates terminaling services in the...
The Federal Trade Commission filed an amicus brief before the U.S. Court of Appeals for the Third Circuit in support of private class action plaintiffs who have challenged the legality of patent settlements between branded and generic manufacturers of the high blood pressure medication K-Dur 20.
At its 10th annual conference in The Hague, the Netherlands, the International Competition Network (ICN) adopted new materials on how to assess market dominance, resolve cartel cases, and manage competition projects effectively. The organization also presented a comprehensive evaluation of how...
Federal Trade Commission staff, in a comment to Massachusetts State Representative Alice Peisch, advised against passage of Massachusetts House Bill 1871, which would impose new administrative requirements on the acquirer of a malt beverage brewer if it subsequently wants to terminate a wholesale...
Federal Trade Commission Chairman Jon Leibowitz and Commissioner William E. Kovacic will participate in the 10th annual International Competition Network (ICN) conference in The Hague, The Netherlands, from May 18-20, 2011. At the conference, senior government antitrust officials, private-sector...
The Federal Trade Commission’s Bureau of Competition has notified Sanofi-Aventis U.S. LLC, Watson Pharmaceuticals, Inc., and Synthon Holding B.V., that it believes the companies violated federal law by failing to inform antitrust authorities about drug patent agreements involving Sanofi’s insomnia...
An association representing 900 physicians in the Amarillo, Texas, area has agreed to a Federal Trade Commission order barring it from jointly negotiating the prices it charges insurance providers. The FTC alleged in a complaint filed with the order that the association, Southwest Health Alliances...
An association representing 900 physicians in the Amarillo, Texas, area agreed to a Commission order barring it from jointly negotiating the prices it charges insurance providers. The FTC alleged in a complaint filed with the order that the association, Southwest Health Alliances,...
The Federal Trade Commission will host a public workshop on June 21, 2011, in Washington, D.C., as part of a project to examine the legal and policy issues surrounding the competition problem of “hold-up” when patented technologies are included in collaborative standards. The workshop will be free...
Following a public comment period, the Federal Trade Commission has approved an application by the Dow Chemical Company to amend an agreement related to its 2001 acquisition of Union Carbide Corporation. In order to obtain FTC approval for the merger, Dow entered into a consent agreement designed...
Pharmaceutical companies struck an unprecedented number of deals in Fiscal Year (FY) 2010 in which the manufacturers of branded products paid potential generic rivals and generic companies agreed to defer the introduction of lower-cost medicines for American consumers, according to an overview of...
On Monday, May 9, 2011, the Federal Trade Commission will host a workshop to seek input on the Proposed Statement of Antitrust Enforcement Policy, which discusses how the federal antitrust agencies will enforce U.S. antitrust laws when competing health care providers create new Accountable Care...
The Federal Trade Commission will require Hikma Pharmaceuticals PLC (Hikma) to divest two generic injectable pharmaceuticals – phenytoin and promethazine – as part of a settlement allowing it to acquire certain assets from Baxter Healthcare Corporation, Inc. (Baxter). Hikma proposes to acquire...

Pages